EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma

Shanshan Zhang, Yan Zhou, Zhonghua Liu, Yuqian Wang, Xiang Zhou, Haiwen Chen, Xinyu Zhang, Yanhong Chen, Qisheng Feng, Xiaoping Ye, Shanghang Xie, Mu-Sheng Zeng und 5 weitere

Cancer Cell · 2025

DOI: 10.1016/j.ccell.2025.04.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025. Verfasst von Shanshan Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University C…. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, CD8-Positive T-Lymphocytes, Early Detection of Cancer, Receptors, Antigen, T-Cell, alpha-beta. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Program key projects, Chinese Academy of Medical Sciences, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To identify nasopharyngeal carcinoma (NPC)-relevant T cell receptors (TCRs), we profile the repertoires of peripheral blood TCRβ chains from 228 NPC patients, 241 at-risk controls positive for serum Epstein-Barr virus (EBV) VCA-IgA antibody, and 251 seronegative controls. We develop a TCR-based signature (T-score) based on 208 NPC-enriched CDR3β sequences, which accurately diagnoses NPC in both the original and independent validation cohorts. Notably, a higher T-score, associated with a shorter time interval to NPC diagnosis, effectively identifies early-stage NPC among EBV-seropositive at-risk individuals prior to clinical diagnosis. These NPC-enriched TCRs react against not only EBV-specific antigens but also non-EBV antigens expressed by NPC cells, indicating a broad range of specificities. Moreover, the abundance of NPC-enriched CD8+ T cells in blood correlates with the infiltration of non-exhausted T cell counterparts in tumors and predicts prolonged survival, suggesting that these NPC-enriched T cells have significant potential for disease monitoring and therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal NeoplasmsCD8-Positive T-LymphocytesEarly Detection of CancerReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesHumansNasopharyngeal CarcinomaMaleFemaleMiddle AgedCarcinomaAdultHerpesvirus 4, HumanAgedEpstein-Barr Virus Infections

Stichwörter der Autor:innen

EBVTCRearly cancer detectionimmunosequencingimmunotherapynasopharyngeal carcinoma

Substanzen

Receptors, Antigen, T-Cell, alpha-beta

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Department of Hematology,…
  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
  • Department of Biostatistics, Columbia University, New York, NY, USA.
  • National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu 215123, China; Key Laboratory of Synthetic…
  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Prenatal Diagnostic Center…
  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; State Key Laboratory of Re…

Förderung

  • Guangzhou Municipal Science and Technology Program key projects
  • Chinese Academy of Medical Sciences
  • National Key Research and Development Program of China
  • Sun Yat-sen University Cancer Center
  • University of Pittsburgh
  • Sun Yat-sen University
  • National Natural Science Foundation of China
  • Peking University

Zitieren

APA

Zhang, S., Zhou, Y., Liu, Z., Wang, Y., Zhou, X., Chen, H., Zhang, X., Chen, Y., Feng, Q., Ye, X., Xie, S., Zeng, M. S., Zhai, W., Zeng, Y. X., Cao, S., Li, G., & Xu, M. (2025). Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2025.04.009

Vancouver

Zhang S, Zhou Y, Liu Z, Wang Y, Zhou X, Chen H, et al. Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma. Cancer Cell. 2025. doi:10.1016/j.ccell.2025.04.009

BibTeX
@article{Zhang2025,
  author = {Zhang, Shanshan and Zhou, Yan and Liu, Zhonghua and Wang, Yuqian and Zhou, Xiang and Chen, Haiwen and Zhang, Xinyu and Chen, Yanhong and Feng, Qisheng and Ye, Xiaoping and Xie, Shanghang and Zeng, Mu-Sheng and Zhai, Weiwei and Zeng, Yi-Xin and Cao, Sumei and Li, Guideng and Xu, Miao},
  title = {Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma},
  journal = {Cancer Cell},
  year = {2025},
  doi = {10.1016/j.ccell.2025.04.009}
}
Kostenlos starten →